Cryoablation: physical and molecular basis with putative immunological consequences

References

• Baust JG, Bischof J, Jiang-Hughes J, et al. Re-purposing thermal ablative therapies. Prostate Cancer Prostatic Dis. 2015;18:87–95.
   PubMed Web of Science ®Google Scholar
• Gage AA, Baust JG. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–186.
   PubMed Web of Science ®Google Scholar
• Hollister WR, Mathew AJ, Baust JG, et al. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cancer cell line. Mol Urol. 1998;2:13–18.
   Google Scholar
• Clarke D, Baust JM, Van Buskirk RG, et al. Addition of anti-cancer agents enhances freezing-induced prostate cancer cell death: implication of mitochondrial involvement. Cryobiology. 2004;49:45–61.
   PubMed Web of Science ®Google Scholar
• Robilotto AT, Baust JM, Van Buskirk RG, et al. Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model. Prostate Cancer Prostatic Dis . 2013;16:41–49.
   PubMed Web of Science ®Google Scholar
• Le Pivert P, Haddad RS, Aller A, et al. Ultrasound guided combined cryoablation and microencapsulated 5-fluorouracil inhibits growth of human prostate tumors in xenogenic mouse model assessed by luminescence imaging. Technol Cancer Res Treat. 2004;3:135–142.
   PubMed Web of Science ®Google Scholar
• Forest V, Peoc'h M, Campos L, et al. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology. 2005;50:29–37.
   PubMed Web of Science ®Google Scholar
• Forest V, Peoc’h M, Campos L, et al. Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model. Lung Cancer. 2006;54:79–86.
   PubMed Web of Science ®Google Scholar
• Baust JG, Gage AA, Robilottto AT, et al. The pathophysiology of thermoablation: optimizing cryoablation. Curr Opin Urol. 2009; 19:127–132.
   PubMed Web of Science ®Google Scholar
• Yantoro C, Soanes WA, Gonder MJ, et al. The production of antibodies to urogenital tissue in consequence of freezing treatment. Immunology. 1967;12:395–410.
   PubMed Web of Science ®Google Scholar
• Shulman S, Brandt EJ, Yantoto C. Studies in cryoimmunology II. Tissue and species specificity of auto-antibody response and comparison with iso-immunization. Immunology. 1968;14:149–158.
   PubMed Web of Science ®Google Scholar
• Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer. J Urol. 1970;104:154–159.
   PubMed Web of Science ®Google Scholar
• Soanes WA, Gonder MJ, Ablin RJ. A possible immuno-cryothermic response in prostatic cancer. Clin Radiol. 1970;21:253–255.
   PubMedGoogle Scholar
• Veenstra JJ, Gibson HM, Freytag S, et al. In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence. OncoImmunology. 2015;4:e989762.
   PubMed Web of Science ®Google Scholar
• Sidana A, Rodriguez R. Urologic applications of cryo-immunology. Korean J Urol. 2009;50:629–634.
   Google Scholar
• Baust JG, Gage AA, Klossner D, et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat. 2007;6:97–110.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
   PubMed Web of Science ®Google Scholar
• Baust JG, Gage AA, Bjerklund Johansen TE, et al. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2014;68:1–11.
   PubMed Web of Science ®Google Scholar
• Sabel MS, Arora A, Su G, et al. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor. Cryobiology. 2006;53:360–366.
   PubMed Web of Science ®Google Scholar
• Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58:1–11.
   PubMed Web of Science ®Google Scholar
• Coventry BJ, Ashdown ML. Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation. Cancer Manag Res. 2012;4:137–149.
   PubMedGoogle Scholar
• Li Y, Zou L, Li Q, et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med. 2010;16:214–218.
   PubMed Web of Science ®Google Scholar
• Balko JM, Cook RS, Vaught DB, et al. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med. 2012;18:1052–1059.
   PubMed Web of Science ®Google Scholar
• Sun Y, Campisi J, Higano C, et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 2012;18:1359–1368.
   PubMed Web of Science ®Google Scholar
• Gupta A, Yang Q, Pandita RK, et al. Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair. Cell Cycle. 2009;8:2198–2210.
   PubMed Web of Science ®Google Scholar
• Ghisolfi L, Keates AC, Hu X, et al. Ionizing radiation induces stemness in cancer cells. PLoS One. 2012;7:e43628.
   PubMed Web of Science ®Google Scholar
• Baust JM, Snyder KK, Santucci KL, et al. Assessment of SCN and argon cryoablation devices in an in vivo-like 3-D tissue engineered prostate and renal cancer model. Cryobiology. 2014;69:198.
   Google Scholar
• Robilotto AT, Baust JM, Santucci K, Snyder KK, Van Buskirk RG, et al. Assessment of a novel supercritical nitrogen cryosurgical device using prostate and renal cancer tissue engineered models. Sage Open Med.
   Google Scholar
• Clarke DM, Robilotto AT, Van Buskirk RG, et al. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007;10:175–184.
   PubMed Web of Science ®Google Scholar
• Clarke DM, Baust JM, Van Buskirk RG, et al. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 2001;42:274–285.
   PubMed Web of Science ®Google Scholar
• Goel R, Anderson K, Slaton J, et al. Adjuvant approaches to enhance cryosurgery. J Biomech Eng. 2009;131:074003
   PubMed Web of Science ®Google Scholar
• Han B, Swanlund DJ, Bischof JC. Cryoinjury of MCF-7 human breast cancer cells and inhibition of post-thaw recovery using TNF-alpha. Technol Cancer Res Treat. 2007;6:625–634.
   PubMed Web of Science ®Google Scholar
• Jiang J, Goel R, Iftekhar MA, et al. Tumor necrosis factor-alpha-induced accentuation in cryoinjury: mechanisms in vitro and in vivo. Mol Cancer Ther. 2008;7:2547–2555.
   PubMed Web of Science ®Google Scholar
• Han B, Iftekhar A, Bischof JC. Improved cryosurgery by use of thermophysical and inflammatory adjuvants. Technol Cancer Res Treat. 2004;3:103–111.
   PubMed Web of Science ®Google Scholar
• Ikekawa S, Ishihara K, Tanaka S, et al. Basic studies of cryochemotherapy in a murine tumor system. Cryobiology. 1985;22:477–483.
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, Niekens S, et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation combination with immune modulation induces anti-tumor immunity. Br J Cancer. 2006;95:896–905.
   PubMed Web of Science ®Google Scholar
• Mobley WC, Loening SA, Narayana AS. Combination perineal cryosurgery and external radiation therapy for adenocarcinoma of prostate. Urology. 1984;24:11–14.
   PubMed Web of Science ®Google Scholar
• Baumann KW, Baust JM, Snyder KK, et al. Characterization of pancreatic cancer cell thermal response to heat ablation or cryoablation. Technol Cancer Res Treat. 2017;16:393–405.
   PubMed Web of Science ®Google Scholar
• Santucci KL, Snyder KK, Baust JM, et al. The use of 1,25a dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer Prostatic Dis. 2011;14:97–104.
   PubMed Web of Science ®Google Scholar
• Baust JM, Klossner DP, Robilotto A, et al. Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis. BJU Int. 2012;109:949–958.
   PubMed Web of Science ®Google Scholar
• Kimura M, Rabbani Z, Mouraviev V, et al. Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study. Urology. 2010;76:764 e14–764 e20.
   PubMed Web of Science ®Google Scholar
• Santucci KL, Baust JM, Snyder KK, et al. Dose escalation of vitamin D3 yields similar cryosurgical outcome to single dose exposure in a prostate cancer model. Cancer Control. 2018;25:107327481875741.
   Web of Science ®Google Scholar
• Garcia-Becerra R, Diaz L, Camacho J, et al. Calcitriol inhibits ether-a go-go potassium channel expression and cell proliferation in human breast cancer cells. Exp Cell Res. 2010;316:433–442.
   PubMed Web of Science ®Google Scholar
• Ferronato MJ, Obiol DJ, Fermento ME, et al. The alkynylphosphonate analogue of calcitriol EM1 has potent anti-metastatic effects in breast cancer. J Steroid Biochem Mol Biol. 2015;154:285–293.
   PubMed Web of Science ®Google Scholar
• Johnson AL, Zinser GM, Waltz SE. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of beta-catenin activity. Oncotarget. 2015;6:16304–16320.
   PubMed Web of Science ®Google Scholar
• Verone-Boyle AR, Shoemaker S, Attwood K, et al. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget. 2016;7:995–1013.
   PubMedGoogle Scholar
• Chen S, Zhu J, Zuo S, et al. 1,25(OH)2D3 attenuates TGF-beta1/beta2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun. 2015;468:130–135.
   PubMed Web of Science ®Google Scholar
• Wierzbicka JM, Binek A, Ahrends T, et al. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. Int J Oncol. 2015;47:1084–1096.
   PubMed Web of Science ®Google Scholar
• Kanemaru M, Maehara N, Chijiiwa K. Antiproliferative effect of 1α,25-dihydroxyvitamin D3 involves upregulation of cyclin-dependent kinase inhibitor p21 in human pancreatic cancer cells. Hepatogastroenterology. 2013;60:1199–1205.
   PubMedGoogle Scholar
• Clarke DM, Robilotto AT, Rhee E, et al. Cryoablation of renal cancer: variables involved in freezing-induced cell death. Technol Cancer Res Treat. 2007;6:69–79.
   PubMed Web of Science ®Google Scholar
• Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180:1993–2004.
   PubMed Web of Science ®Google Scholar
• Cohen JK, Miller RJJ, Ahmed S, et al. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71:515–518.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. A study of pre-operative treatment with cryoablation and immune therapy in early stage breast cancer. 2018 [cited 2018 May 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT02833233
   Google Scholar
• ClinicalTrials.gov [Internet]. Phase I clinical trial of cryoimmunotherapy against prostate cancer (CryoIT). 2018 [cited 2018 May 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT02423928
   Google Scholar
• Clinicaltrials.gov [Internet]. A study of pre-operative treatment with cryoablation and immune therapy in early stage breast cancer. 2018 [cited 2018 May 2] Available from: https://clinicaltrials.gov/ct2/show/NCT02833233
   Google Scholar
• ClinicalTrials.gov [Internet]. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery. 2018 [cited 2018 May 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT03325101
   Google Scholar